How Will Regulatory Approvals Boost the Ultomiris Drug Market?

Ajouter une nouvelle offre d'emploi Autre

2025-12-22 09:49:46 -

Ultomiris Drug Market Overview: Growth, Trends, and Future Projections The Ultomiris drug market is experiencing robust expansion, driven by rising demand for advanced treatments in rare complement-mediated disorders. Ultomiris (ravulizumab-cwvz), a long-acting C5 complement inhibitor developed by Alexion Pharmaceuticals (now a subsidiary of AstraZeneca), has emerged as a...

0 Commentaires 0 Parts 449 Vue 0 Aperçu